Familial Chylomicronemia Syndrome is really a genetic condition characterized by an inability of your body to digest fats mainly triglyceride. In Familial Chylomicronemia Syndrome, the lipoprotein lipase (LPS) is not functional, which can be the enzyme that reduces chylomicrons in the blood. Healthcare providers can clinically diagnosed FCS by trying to find acute pancreatitis, abdominal pain, uncontrolled diabetes, excess alcohol intake and hypertriglyceridemia.
FCS is estimated to affect 1-2 individuals per million. This is a serious disease that prevents your body from breaking down the fat consumed through the diet, or triglycerides. According to the U.S. Food and Drug Administration (FDA), around 7,000 rare diseases affect over 30 million people in the United States. Many rare conditions/diseases are life-threatening and many of them do not have treatments. Similarly, there is no FDA-approved Familial Chylomicronemia Syndrome Treatment.
Read More@ https://bit.ly/3auG6rP
